BEST TOOL: The adapted Beers’ Criteria (HCFA Guidelines for Potentially Inappropriate Medications in the Elderly) identifies medications noted by an expert panel to have potential risks that outweigh potential benefits of the drug. The criteria are appropriate for persons older than 65 years of age, regardless of their level of frailty. The criteria provide a rating of severity for adverse outc...

OBJECTIVE: To analyze the frequency, profile, and additional variables associated with prescription of potentially inappropriate medications (PIM) to older adults in primary care, evaluate physicians’ knowledge about these medications. METHODS: A cross-sectional study was conducted based on data from patient records for period January 2014 December 2017 a city located state Minas Gerais. The fr...

The global population of multimorbid older people is growing steadily. Multimorbidity is the principal cause of complex polypharmacy, which in turn is the prime risk factor for inappropriate prescribing and adverse drug reactions and events. Those who prescribe for older frailer multimorbid people are particularly prone to committing prescribing errors of various kinds. The causes of prescribin...

Objective: Studies have shown that older people suffer from chronic diseases more than other age groups, resulting in more consumption of drugs. Age-related changes in the pharmacokinetics and pharmacodynamics of drugs alter drug disposition and response to medications in elderly patients. Recognizing these medications and avoiding their prescription for the elderly prevents the adverse effects...

BACKGROUND Inappropriate medication use in elderly patients has been linked to a large share of adverse drug reactions and to excess health care utilization. METHODS Trends in the prevalence of potentially inappropriate drug prescribing at ambulatory care visits by elderly persons from 1995 to 2000 were examined with data from office-based physicians in the National Ambulatory Medical Care Su...

Purpose The purpose of these guidelines is to assist practitioners in improving their antineoplastic medication-use system and error-prevention programs. They supplement ASHP’s Guidelines on Preventing Medication Errors in Hospitals and address error prevention within diverse health care settings. Further, these guidelines provide updated general guidance to include a standard definition of a “...